BRAIN CANCER
Clinical trials for BRAIN CANCER explained in plain language.
Never miss a new study
Get alerted when new BRAIN CANCER trials appear
Sign up with your email to follow new studies for BRAIN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New brain cancer drug enters human testing
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LMP744 in adults whose aggressive brain cancer (glioblastoma) has returned after standard treatment. The main goal is to see if the drug can shrink or stabilize tumors and is safe for patients. Participants will receive the drug…
Matched conditions: BRAIN CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Brain 'Remapping' implant could let surgeons cut out more cancer
Disease control Not yet recruitingThis pilot study is testing a new approach to help surgeons remove more of a brain tumor while protecting critical functions like movement and speech. Researchers will implant a small device that gently stimulates the brain to temporarily weaken a function, while physical therapy…
Matched conditions: BRAIN CANCER
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for fighting deadly brain tumors: experimental drug combo enters testing
Disease control Not yet recruitingThis study is testing whether adding a new oral drug called silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of aggressive brain cancer (glioblastoma) live longer without their cancer getting worse. It will involve about 162 newly diagnosed p…
Matched conditions: BRAIN CANCER
Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Glowing dye could light the way for brain surgeons
Diagnosis Not yet recruitingThis early-stage study is testing a special fluorescent dye to see if it can help surgeons better see brain tumors during removal surgery. About 30 adults scheduled for brain tumor surgery will receive the dye by IV 1-5 days before their operation. During surgery, a special camer…
Matched conditions: BRAIN CANCER
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
New hope for clearer, less painful recovery after brain surgery
Symptom relief Not yet recruitingThis study aims to see if a drug called dexmedetomidine can help patients feel less pain and be less confused after brain surgery. It will involve 60 adults having planned brain surgery. Researchers will compare the drug to a placebo to see if it lowers pain scores, reduces the n…
Matched conditions: BRAIN CANCER
Phase: NA • Sponsor: University of Malaya • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
VR headsets may help heal minds after brain cancer
Symptom relief Not yet recruitingThis study is testing whether playing virtual reality (VR) games can help brain cancer survivors who are struggling with memory, focus, and thinking after their treatment ends. Researchers will compare the VR games to traditional paper puzzles to see which is more helpful and eas…
Matched conditions: BRAIN CANCER
Phase: NA • Sponsor: University of Cincinnati • Aim: Symptom relief
Last updated Mar 16, 2026 15:27 UTC
-
Glowing drug lights up deadly brain tumors for surgeons
Knowledge-focused Not yet recruitingThis early study is testing a new version of a cancer drug (nivolumab) that has been made to glow. The goal is to see if this glowing drug can safely help surgeons better see and map out aggressive brain tumors during surgery. The study will involve 38 adults with high-grade glio…
Matched conditions: BRAIN CANCER
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Knowledge-focused
Last updated Apr 04, 2026 02:06 UTC